Literature DB >> 16801598

Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes.

Jang Yel Shin1, Young Goo Shin, Choon Hee Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16801598     DOI： 10.2337/dc06-0631

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  20 in total

Review 1.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Association of gene polymorphisms in RANKL/RANK/OPG system with hypertension and blood pressure in Chinese women.

Authors:  P Duan; Z-M Wang; J Liu; L-N Wang; Z Yang; P Tu
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

3.  Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure.

Authors:  G Loncar; B Bozic; S Dimkovic; N Prodanovic; Z Radojicic; V Cvorovic; B Putnikovic; V Popovic
Journal:  J Endocrinol Invest       Date:  2010-09-02       Impact factor: 4.256

4.  Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.

Authors:  Abdullah Ozkok; Yasar Caliskan; Tamer Sakaci; Gaye Erten; Gonca Karahan; Alper Ozel; Abdulkadir Unsal; Alaattin Yildiz
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

5.  Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients.

Authors:  Janice J Hwang; Jeffrey Wei; Suhny Abbara; Steven K Grinspoon; Janet Lo
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

Review 6.  Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily.

Authors:  Allan Flyvbjerg
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

7.  TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL.

Authors:  Federica Corallini; Paola Secchiero; Antonio Paolo Beltrami; Daniela Cesselli; Elisa Puppato; Roberto Ferrari; Carlo Alberto Beltrami; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

Review 8.  Osteoprotegerin, vascular calcification and atherosclerosis.

Authors:  Ann Van Campenhout; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2008-10-09       Impact factor: 5.162

9.  Expression of osteoprotegerin in placenta and its association with preeclampsia.

Authors:  Pei Shen; Yunhui Gong; Tao Wang; Yueyue Chen; Jin Jia; Shanshan Ni; Bin Zhou; Yapin Song; Lin Zhang; Rong Zhou
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  Osteoprotegerin as a marker of atherosclerosis in diabetic patients.

Authors:  Areti Augoulea; Nikolaos Vrachnis; Irene Lambrinoudaki; Konstantinos Dafopoulos; Zoe Iliodromiti; Angelos Daniilidis; Michail Varras; Andreas Alexandrou; Efthymios Deligeoroglou; George Creatsas
Journal:  Int J Endocrinol       Date:  2013-01-17       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.